Company intelligence / Profile preview

Luxa Biotechnology

Fort Lee* or Albany/Rensselaer* (*see below), New Jersey* or New York* (*see below), USAluxabiotech.com ↗

Ownership: Private
Development stage: Phase 1

Overview

Luxa Biotechnology is a clinical-stage biotech developing a novel adult retinal pigment epithelial stem cell therapy for dry age-related macular degeneration. Its lead candidate, RPESC-RPE–4W, has shown encouraging results in a first-in-human Phase 1/2a trial with vision improvements and no serious adverse events reported. The company received FDA RMAT designation for this program and is advancing through dose escalation cohorts.[2][5][9]

Therapeutic areas: Ophthalmology
Modalities: Adult stem cell therapy (specifically adult retinal pigment epithelial stem cells, RPESC)Cell therapy
Industry: Biotech

Drug pipeline

1 asset

RPESC-RPE-4W

Partnerships

University of Michigan Kellogg Eye Center – clinical site/collaborator[5][9]Cedars Sinai Biomanufacturing Center – manufacturing partner[5]Emmes Corporation – data management/CRO support partner[7]California Institute for Regenerative Medicine – funding/collaboration support partner[7]

Beyond the preview

Go deeper on Luxa Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Luxa Biotechnology.

Explore the full profile